Detalhe da pesquisa
1.
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).
J Infect Dis
; 226(11): 1877-1881, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429382
2.
Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021.
Euro Surveill
; 26(46)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794537
3.
Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic review.
Lancet Digit Health
; 6(2): e131-e144, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278615
4.
Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review.
Pharmacoeconomics
; 41(5): 467-480, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529838
5.
Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models.
Pharmacoeconomics
; 41(6): 693-707, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988896
6.
Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way Forward.
Pharmacoeconomics
; 41(7): 787-802, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905570
7.
Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
Lancet Healthy Longev
; 3(7): e470-e480, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35813279
8.
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.
Lancet Healthy Longev
; 3(1): e13-e21, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935001
9.
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.
Lancet Healthy Longev
; 3(7): e461-e469, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35813280
10.
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection.
Nat Aging
; 2(6): 536-547, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37118449
11.
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
Lancet Infect Dis
; 21(11): 1529-1538, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174193
12.
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Lancet Healthy Longev
; 2(12): e811-e819, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873592